美国 · SEC FORM 4
QUEST DIAGNOSTICS INC
DGX · NYSE · CIK 0001022079 · Healthcare · Diagnostics & Research
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
29 同一窗口内观察到的 Form 4 交易行
7 sales · 22 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 10 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot.—
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 3,417,577
- 上期报告
- 3,600,559
- 日均成交量
- 1,268,667
- 回补天数
- 2.7
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
本地 Form 4 历史中没有合资格的代码 P 股票买入。
Form 4 申报证据
126 transaction lines in the latest 365-day window; 719 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Davis J. E. | 卖出 (S) | Common Stock | 10,000 | USD 242.72 | USD 2,427,200 | SEC 申报 ↗ |
| 2026-08-28 | PREVOZNIK MICHAEL E | 卖出 (S) | Common Stock | 22,677 | USD 243.12 | USD 5,513,168 | SEC 申报 ↗ |
| 2026-08-28 | PREVOZNIK MICHAEL E | 期权行权／转换 (M) | Common Stock | 22,677 | USD 112.17 | USD 2,543,679 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Davis J. E. | 卖出 (S) | Common Stock | 10,000 | USD 242.72 | USD 2,427,200 | SEC 申报 ↗ |
| 2026-08-28 | PREVOZNIK MICHAEL E | 卖出 (S) | Common Stock | 22,677 | USD 243.12 | USD 5,513,168 | SEC 申报 ↗ |
| 2026-08-28 | PREVOZNIK MICHAEL E | 期权行权／转换 (M) | Common Stock | 22,677 | USD 112.17 | USD 2,543,679 | SEC 申报 ↗ |
| 2026-08-28 | PREVOZNIK MICHAEL E | 赠与 (G) | Common Stock | 1,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-28 | DELANEY MARK E | 卖出 (S) | Common Stock | 1,600 | USD 235.18 | USD 376,288 | SEC 申报 ↗ |
| 2026-07-22 | SAMAD SAM | 奖励／授予 (A) | Common Stock | 102 | USD 206.81 | USD 21,095 | SEC 申报 ↗ |
| 2026-07-22 | Plewman Patrick | L (L) | Common Stock | 46 | USD 206.81 | USD 9,513 | SEC 申报 ↗ |
| 2026-07-22 | MAIN TIMOTHY L | L (L) | Common Stock | 21 | USD 206.81 | USD 4,343 | SEC 申报 ↗ |
| 2026-07-22 | Lassiter Wright III | L (L) | Common Stock | 6 | USD 206.81 | USD 1,241 | SEC 申报 ↗ |
| 2026-07-22 | KUPPUSAMY KARTHIK | L (L) | Common Stock | 37 | USD 206.81 | USD 7,652 | SEC 申报 ↗ |
| 2026-07-22 | Gregg Vicky B | 奖励／授予 (A) | Common Stock | 72 | USD 206.81 | USD 14,890 | SEC 申报 ↗ |
| 2026-07-22 | DELANEY MARK E | L (L) | Common Stock | 34 | USD 206.81 | USD 7,032 | SEC 申报 ↗ |
| 2026-07-22 | CARTER ROBERT B | L (L) | Common Stock | 11 | USD 206.80 | USD 2,275 | SEC 申报 ↗ |
| 2026-06-04 | KUPPUSAMY KARTHIK | 卖出 (S) | Common Stock | 8,147 | USD 200.00 | USD 1,629,400 | SEC 申报 ↗ |
| 2026-06-04 | KUPPUSAMY KARTHIK | 期权行权／转换 (M) | Common Stock | 8,147 | USD 124.22 | USD 1,012,040 | SEC 申报 ↗ |
| 2026-06-01 | Davis J. E. | 卖出 (S) | Common Stock | 10,000 | USD 194.14 | USD 1,941,400 | SEC 申报 ↗ |
| 2026-05-20 | WENTWORTH TIMOTHY C | 奖励／授予 (A) | Common Stock | 1,142 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | RING TIMOTHY M | 奖励／授予 (A) | Common Stock | 1,142 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | PFEIFFER GARY M | 奖励／授予 (A) | Common Stock | 1,142 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | MORRISON DENISE M | 奖励／授予 (A) | Common Stock | 1,142 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | MAIN TIMOTHY L | 奖励／授予 (A) | Common Stock | 1,142 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Lassiter Wright III | 奖励／授予 (A) | Common Stock | 1,142 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Gregg Vicky B | 奖励／授予 (A) | Common Stock | 1,142 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Doi Tracey | 奖励／授予 (A) | Common Stock | 1,142 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Diaz Luis | 奖励／授予 (A) | Common Stock | 1,142 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | CARTER ROBERT B | 奖励／授予 (A) | Common Stock | 1,142 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-20 | SAMAD SAM | 奖励／授予 (A) | Common Stock | 108 | USD 194.70 | USD 21,028 | SEC 申报 ↗ |
| 2026-04-20 | Plewman Patrick | L (L) | Common Stock | 49 | USD 194.70 | USD 9,540 | SEC 申报 ↗ |
| 2026-04-20 | Lassiter Wright III | L (L) | Common Stock | 6 | USD 194.70 | USD 1,168 | SEC 申报 ↗ |
| 2026-04-20 | KUPPUSAMY KARTHIK | L (L) | Common Stock | 39 | USD 194.70 | USD 7,593 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | DGX |
| CIK | 0001022079 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 719 transaction lines from 2020-01-02 to 2026-09-01 0 P purchase lines · 190 S sale lines · 529 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.